Europol records surge in fake pharma goods during COVID-19 crisis

20-04-2020

Sarah Morgan

Europol records surge in fake pharma goods during COVID-19 crisis

Trial / Shutterstock.com

Demand for counterfeit products, particularly fake pharmaceutical and healthcare products, has surged and will continue throughout the current COVID-19 crisis, despite potentially harmful effects on consumers, according to Europol.


COVID-19, coronavirus, counterfeit treatments, counterfeits, counterfeit medicines, Europol, IP crime, pandemic

WIPR